These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 39300449)
1. The role of KRT7 in metastasis and prognosis of pancreatic cancer. Xu C; Wang S; Sun Y Cancer Cell Int; 2024 Sep; 24(1):321. PubMed ID: 39300449 [TBL] [Abstract][Full Text] [Related]
2. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer. Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300 [TBL] [Abstract][Full Text] [Related]
3. Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape. Liu H; Li Z; Zhang L; Zhang M; Liu S; Wang J; Yang C; Peng Q; Du C; Jiang N Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371833 [TBL] [Abstract][Full Text] [Related]
4. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer. Liu Y; Wang T; Fang Z; Kong J; Liu J J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871 [TBL] [Abstract][Full Text] [Related]
5. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma. Li Y; Su Z; Wei B; Liang Z Int J Gen Med; 2021; 14():2677-2694. PubMed ID: 34188523 [TBL] [Abstract][Full Text] [Related]
6. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer. Yang J Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571 [TBL] [Abstract][Full Text] [Related]
7. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma. Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578 [TBL] [Abstract][Full Text] [Related]
8. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069 [TBL] [Abstract][Full Text] [Related]
9. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation. Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253 [TBL] [Abstract][Full Text] [Related]
10. Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation. Quan Y; Zhang X; Ping H Cancer Cell Int; 2022 Jan; 22(1):33. PubMed ID: 35045837 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-216a targets WT1 expression and regulates KRT7 transcription to mediate the progression of pancreatic cancer-A transcriptome analysis. Wang W; Wang J; Yang C; Wang J IUBMB Life; 2021 Jun; 73(6):866-882. PubMed ID: 33759343 [TBL] [Abstract][Full Text] [Related]
12. Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation. Zhou W; Lin J; Liu J; Zhang R; Fan A; Xie Q; Hong L; Fan D Aging (Albany NY); 2023 Feb; 15(3):846-865. PubMed ID: 36791151 [TBL] [Abstract][Full Text] [Related]
13. A prognostic binary classifier comprised of five critical mRNAs stratified pancreatic cancer patients following resection. Lu Y; Zhou T; Lu M Heliyon; 2024 Jun; 10(11):e31302. PubMed ID: 38828350 [TBL] [Abstract][Full Text] [Related]
14. Risk Score Prediction Model of Prognosis in GC Patients by Age and Gender Combined With m6A Modification Genes FTO and RBM15. Yue L; Zhang R; Chen S; Duan G Front Cell Dev Biol; 2022; 10():710708. PubMed ID: 35433701 [No Abstract] [Full Text] [Related]
15. WTAP/IGF2BP3-mediated GBE1 expression accelerates the proliferation and enhances stemness in pancreatic cancer cells via upregulating c-Myc. Jin W; Yao Y; Fu Y; Lei X; Fu W; Lu Q; Tong X; Xu Q; Su W; Hu X Cell Mol Biol Lett; 2024 Jul; 29(1):97. PubMed ID: 38961325 [TBL] [Abstract][Full Text] [Related]
16. Identification of a New m6A Regulator-Related Methylation Signature for Predicting the Prognosis and Immune Microenvironment of Patients with Pancreatic Cancer. Zou T; Shi D; Wang W; Chen G; Zhang X; Tian Y; Gong P Mediators Inflamm; 2023; 2023():5565054. PubMed ID: 37181810 [TBL] [Abstract][Full Text] [Related]
17. Multiomics profile and prognostic gene signature of m6A regulators in uterine corpus endometrial carcinoma. Wang Y; Ren F; Song Z; Wang X; Ma X J Cancer; 2020; 11(21):6390-6401. PubMed ID: 33033522 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of KRT7 in bladder cancer prognosis. Song J; Wu Y; Chen Z; Zhai D; Zhang C; Chen S Int J Biol Markers; 2024 Jun; 39(2):158-167. PubMed ID: 38321777 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment. Cao PW; Liu L; Li ZH; Cao F; Liu FB Front Genet; 2022; 13():853471. PubMed ID: 35547245 [TBL] [Abstract][Full Text] [Related]
20. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma. Chen D; Guo W; Yu H; Yang J Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]